Accurate, proper drug testing is imperative when choosing a diagnostic lab.

Many employers use these testing methods as part of their employment pre-screens, post accident, random testing or under reasonable suspicion. The most common drug test is known as the SAMHSA 5 or NIDA-5.   This tests for the 5 most common illegal drugs. AMS Laboratory follows strict specimen collection protocols to insure accurate, rapid processing of results. AMS offers the following types of drug screening tests (blood, saliva, hair, urine and sweat) for employers, individuals and teens: Blood testing for illicit and prescription drugs, alcohol and nicotine. Hair Follicle Drug Testing (Five-Panel).  This test indicates the presence of the following drugs:  Amphetamines/Meth, Cannabinoids (marijuana and hash), Cocaine, Opiates (Heroin, opium, codeine and morphine) and Phencyclidines (PCP). Screening using fingernails (10 Panel Drug Test). This method of drug testing can show drug us going back as far as 90-180 days.  Using either fingernail or toenail samples, we’re able to test for the same drugs in the Five Panel, plus the following additional substances:  Barbiturates, Benzodiazepines (Valium, Sana, Serax and Rohypnol), methadone (used to control opiate addiction, usually heroin), and propoxyphene (Darvon).  The presence of these substances stays in the nails longer than in blood, saliva or hair, so it provides the longest window of evidence of the ingestion and use of legal (prescription) and illegal substances.Saliva/oral drug screening tests are the least invasive, quickest tests to administer.  They can detect the presence of nicotine (tobacco use), marijuana, cocaine, methamphetamine, and PCP.  Negative results come back same day.  A positive test can take 72 hours.


Prescription/Illicit Drug Compliance Program Testing: According to the National Survey on Drug Use and Health which was conducted in January 2014, 9.2% of all Americans abuse illegal substances or abuse legal prescription medication. Patients who acknowledge abuse of ONE substance often secretly abuse other substances. In a study of 248 treatment-seeking alcoholics, 68% reported using illicit drugs in the past 90 days (Staines GL et al., J Addict Dis2001;20(4).53-69)


Gives you real information on your patient’s substance usage (patients may tend to purposefully withhold information from you about their illicit drug use due to embarrassment or fear (Chen, Fang, Shyu, & Lin, 2006) Implement routine drug/alcohol testing in your practice which can protect your potential liability risk Prevent dangerous medication interactions during surgery or other medical procedures Experience exemplary customer service and support (unparalleled within industry). Purchase point-of-care cups at THE LOWEST price available within the industry. Obtain your results via immunoassay within 48 hours and your confirmation results thereafter. Allow us to provide you with an on-site collector. Perform oral-fluid drug testing in lieu of urine if indicated in a specific patient. Determine the reasons for changes in pain symptoms in your patients. Detect Illicit drug usage in your patients which may not occur at the first visit, but can begin at any time in the treatment of patient. Detect prescription medication diversion in your patients. Ensure Compliance with prescription drug protocol by your patients. Consult with toxicology specialists / MRO at any time \r\n\r\nIntegrate drug compliance seamlessly into your practice by our experienced AMS representatives with hands-on training Access online patient reports with ease.  Whether it is integrating a collector or phlebotomist into your practice, or setting you up with a web portal, we make it simple to obtain your easy-to-read reports. Be aware of valuable information as to potential drug interactions which may be impeding a patient’s progress on prescribed medications


AMS MEDICAL LABORATORIES TESTING RECOMMENDATIONS: can be customized to reflect your preferences. All patients should be tested quarterly to determine chronic drug abuse new drug abuse. Patients at high risk for adverse outcomes should be tested at least monthly (patients on opioids or benzodiazepine stronges).  Patients at low risk on a stable dose of medication should be tested quarterly (proactively discover new drug abuse noncompliance). AMS medical laboratories can provide you with 12-panel, state-of-the-art, point-of-care urine cups (as well as the alternative—oral-fluid testing kits).